| scholarly article | Q13442814 |
| P2093 | author name string | Mario Pérez | |
| Alvaro Abarzúa-Araya | |||
| Eugenia León | |||
| Felix Fich | |||
| Yalile Nauhm | |||
| P2860 | cites work | Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry | Q33445758 |
| Utility of inoculum counting (Walshe and English criteria) in clinical diagnosis of onychomycosis caused by nondermatophytic filamentous fungi | Q33972502 | ||
| Terbinafine in onychomycosis with involvement by non-dermatophytic fungi | Q34341344 | ||
| Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance | Q34641319 | ||
| Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility | Q35249261 | ||
| Candidal onychomycosis: a mini-review | Q37502831 | ||
| Laboratory-based epidemiological study of superficial fungal infections | Q38962495 | ||
| Onychomycosis in Iran: epidemiology, causative agents and clinical features. | Q39897283 | ||
| Antifungal agents: an overview. Part II. | Q40449449 | ||
| Epidemiologic surveillance of cutaneous fungal infection in the United States from 1999 to 2002. | Q40516116 | ||
| Fungal echinocandin resistance. | Q41848811 | ||
| Onychomycosis in Cali, Colombia | Q42167980 | ||
| Clinical pathogenesis of candidemia caused by non-albicans Candida species | Q43234824 | ||
| Characterization of yeasts colonizing in healthy individuals | Q43447660 | ||
| Onychomycosis-causing yeasts in four Mexican dermatology centers and their antifungal susceptibility to azolic compounds | Q43540285 | ||
| Itraconazole vs amphotericin B: in vitro comparative evaluation of the minimal inhibitory concentration (MIC) against clinically isolated yeasts | Q43724707 | ||
| Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species | Q44380989 | ||
| Onychomycosis in São Paulo, Brazil. | Q46020662 | ||
| The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy | Q46163150 | ||
| In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates | Q46424835 | ||
| Distribution and antifungal susceptibility of Candida clinical isolations coming from six health care centers in the metropolitan area of Caracas, Venezuela (years 2003-2005) | Q46703644 | ||
| Characteristics of superficial mycoses in Malta | Q47975190 | ||
| Study of onychomycosis in Córdoba, Spain: prevailing fungi and pattern of infection. | Q50934324 | ||
| Study of onychomycosis: prevailing fungi and pattern of infection. | Q51759983 | ||
| Onychomycosis is no longer a rare finding in children. | Q53749159 | ||
| Candida krusei fungemia. An escalating serious infection in immunocompromised patients. | Q54035969 | ||
| Azole drug resistance in Candida species | Q54261117 | ||
| Amphotericin B tolerance: a characteristic of Candida parapsilosis not shared by other Candida species. | Q54504401 | ||
| The diagnosis of nondermatophyte mold onychomycosis | Q58404466 | ||
| Fungi in nails | Q68379408 | ||
| [Variations in the etiology of superficial mycoses in 2 hospital services of the metropolitan region] | Q68701672 | ||
| [Superficial dermatomycoses. Study of patients at the Central Santiago Metropolitan Health Service] | Q71108734 | ||
| In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole | Q73053427 | ||
| Nosocomial candidaemias due to species other than Candida albicans in cancer patients. Aetiology, risk factors, and outcome of 45 episodes within 10 years in a single cancer institution | Q73133251 | ||
| Mycoses in hematological patients | Q73320513 | ||
| Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices: a multicenter canadian survey of 15,000 patients | Q74038772 | ||
| Epidemiology and in vitro activity of antimycotics against candidal vaginal/skin/nail infections in Singapore | Q74445011 | ||
| Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study | Q79631925 | ||
| Identification and in vitro antifungal susceptibility testing of 200 clinical isolates of Candida spp. responsible for fingernail infections | Q80435303 | ||
| Onychomycosis in Adana, Turkey: a 5-year study | Q81314835 | ||
| Retrospective study of onychomycosis in Italy: 1985-2000 | Q81337823 | ||
| [Causative agents of onychomycosis--a retrospective study] | Q83179516 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Candida parapsilosis | Q144068 |
| candidiasis | Q273510 | ||
| emerging pathogen | Q108429945 | ||
| P304 | page(s) | 24-29 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | Indian Journal of Dermatology | Q15710013 |
| P1476 | title | Candida parapsilosis and Candida guillermondii: emerging pathogens in nail candidiasis | |
| P478 | volume | 59 |
| Q64083232 | Different toenail onychomycosis due to and in an immunocompetent young adult |
| Q40608450 | Epidemiology of onychomycosis in Crete, Greece: a 12-year study |
| Q38882704 | Molecular identification and antifungal susceptibility profiles of Candida parapsilosis complex species isolated from culture collection of clinical samples |
| Q40853170 | Onychomycosis due to Candida parapsilosis in a Child with Ventricular Septal Defect: An Unusual Predisposition |
| Q41543412 | Onychomycosis in Israel: epidemiological aspects |
| Q50457886 | [Infections of finger and toe nails due to fungi and bacteria]. |
Search more.